MMP7 and systemic sclerosis: These observations suggest that MMP7 may, directly or indirectly, contribute to lung fibrosis, and may serve as a biomarker for SSc progression (Moinzadeh et al., 2011; Stock et al., 2019; Abo Gabal et al., 2020).